Cite

HARVARD Citation

    Kumagai, T. et al. (2018). Dasatinib cessation after deep molecular response exceeding 2 years and natural killer cell transition during dasatinib consolidation. Cancer science. 109 (1), pp. 182-192. [Online]. 
  
Back to record